1 2 3 4 5

читать далее ... ce First results from Danish Database (DANBIO) Scand J Rheum, 2005, 3440-4 14 Zmk A, Listing J., Kary S et all Traetment continuation on patients receiving biological agents or conventional DMARD therapy Ann Rheum Dis, 2005, 64, 1274-79 15 Straub FIH, Sarzi-Puttmi P, Altzem F etall Anti-TNF antibody treatment does not change serum levels of corf/so/ binding globulin in patients with rheumatoid arthritis but it increases androstenedione relative to cortisol Ann Rheum Dis, 2005, 64, 1353-56 16 KruithoIfE, Van der Bosch F, Baeten D etall Repeated infusions of mfliximab, a chimenc anti-TNF-? monoclonal antibody, in patients with active spondyloarthropafhy one year follow up Ann Rheum Dis, 2002, 61, 207-12 17 Antoni CE, Kavanugh A, Kirkhan В et all Sustained benefites of mfliximab therapy for dermatologic and articular manifestations of psonatic arthritis resultes from the mfliximab multinational PsA controlled trial (IMPACT) Arth Rheum, 2005, 52, 1227-36 18 Marzo-Ortega H, Me Gonagle D, Jarrett S et all Infliximab in combination with methotrexate in active ankylosing spondilytis a clinical and imaging study Ann Rheum Dis, 2005, 64, 1568-75 19 Эрдес Ш Ф, ГалушкоЕА и соавт Распространенность суставного синдрома в России Науч -практ реем, 2005, 3, № 576 20 Siegle I, Klein Т, Backman J Т et all Expression of cyclooxygenase-1 and cyclooxygenase-2 in human synovial tissue Arth Rheum, 1998,41 122-9 21 Turnbach ME, Sefh Spraggms D, Randich A Spinal administration of PGE2f or PGF2f primary produces mechanical hyperalgesia that is mediated by nociceptwe specific spinal dorsal horn neurons Pain, 2002, 97, 33-45 22 Berg J, Fellier H, Chnstoph Т et all The analgesic NSAID lornoxicam inhibits COX-1/2, inducible nitric oxide synthase (iNOS) and the formation of interleukm-6 in vitro Inflamm Res , 1999, 48 (7) 369-79 23 Me Cormac K The spinal actions of NSAIDs and the dissociation between their anti-inflammatory and analgesic effects Drugs 1994, 47, SuppI 5, 28 - 46 24 Pruss T P, Stressing H et all Overview of the pharmacological properties, pharmacokmetics and animal safety assessment of lornoxicam Postgrad Med J, 1990, 66, SuppI 4 S 18-21 25 Балабанова P M Лечение болевого синдрома в ревматологии новым НПВП -ксефокамом Боль и ее лечение, 1999, 10, 15-18 26 Kuzucuoglu T, Yener Т, Temize F et all Lornoxicam and Tramadol applications for postoperative pain management in lumbar disc surgery Regional Anesth. and Pain Med, 2005, 30, SuppI 1, P 81 27 Kremastmou F, Papadima A, Fotlou G et all Combination of morphine and lornoxicam via PCA pump for postoperative IV analgesia after spinal anesthesia. Regional Anesth and Pain Med, 2005, 30, SuppI 1, P 81 28 Berry И, Bird НА, Black С et all A double blind, multicenter, placebo controlled trial of lornoxicam in patients with ОА of the hip and knee Ann Rheum Dis, 1992, 51(2), 238-42 29 Kidd В, Frenzel W et all A multicenter, randomized, double blind study comparing lornoxicam with diclofenac in osteoarthntis J Rheum., 1996, 23 Источник: Балабанова Р.М., Каптаева А.К. Русский медицинский журнал. 2006. Т.14. №4. С.278-281